AU2004272170B2 - Synthetic antimicrobial polypeptides - Google Patents

Synthetic antimicrobial polypeptides Download PDF

Info

Publication number
AU2004272170B2
AU2004272170B2 AU2004272170A AU2004272170A AU2004272170B2 AU 2004272170 B2 AU2004272170 B2 AU 2004272170B2 AU 2004272170 A AU2004272170 A AU 2004272170A AU 2004272170 A AU2004272170 A AU 2004272170A AU 2004272170 B2 AU2004272170 B2 AU 2004272170B2
Authority
AU
Australia
Prior art keywords
pro
arg
val
leu
phe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2004272170A
Other languages
English (en)
Other versions
AU2004272170A1 (en
Inventor
Hans-Henrik Kristensen Hoegenhaug
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes Biopharma DK AS
Original Assignee
Novozymes Adenium Biotech AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes Adenium Biotech AS filed Critical Novozymes Adenium Biotech AS
Publication of AU2004272170A1 publication Critical patent/AU2004272170A1/en
Assigned to NOVOZYMES ADENIUM BIOTECH A/S reassignment NOVOZYMES ADENIUM BIOTECH A/S Request for Assignment Assignors: NOVOZYMES A/S
Application granted granted Critical
Publication of AU2004272170B2 publication Critical patent/AU2004272170B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
AU2004272170A 2003-09-12 2004-09-13 Synthetic antimicrobial polypeptides Expired - Fee Related AU2004272170B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200301324 2003-09-12
DKPA200301324 2003-09-12
PCT/DK2004/000606 WO2005026204A2 (en) 2003-09-12 2004-09-13 Synthetic antimicrobial polypeptides

Publications (2)

Publication Number Publication Date
AU2004272170A1 AU2004272170A1 (en) 2005-03-24
AU2004272170B2 true AU2004272170B2 (en) 2011-04-07

Family

ID=34306686

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004272170A Expired - Fee Related AU2004272170B2 (en) 2003-09-12 2004-09-13 Synthetic antimicrobial polypeptides

Country Status (10)

Country Link
EP (1) EP1664107A2 (ja)
JP (1) JP2007527228A (ja)
CN (2) CN101113173A (ja)
AU (1) AU2004272170B2 (ja)
BR (1) BRPI0414253A (ja)
CA (1) CA2538085C (ja)
IL (1) IL174092A (ja)
NZ (1) NZ545815A (ja)
WO (1) WO2005026204A2 (ja)
ZA (1) ZA200601999B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20041892D0 (no) * 2004-05-07 2004-05-07 Uni I Tromso Novel crustacean proline-rich peptides
US8124721B2 (en) 2005-10-04 2012-02-28 Inimex Pharmaceuticals Inc. Peptides for modulating innate immunity
JP2012100639A (ja) * 2010-11-09 2012-05-31 Kai:Kk 酵素処理液を使用する洗浄、塗布および抗菌処理方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468516B (sv) * 1991-06-14 1993-02-01 Kabigen Ab Nya polypeptider vilka kan utvinnas fraan tunntarmen och deras anvaendning
EP0665239A1 (en) * 1994-01-26 1995-08-02 Consiglio Nazionale Delle Ricerche Peptide derivatives of bactenecin endowed with antibacterial activity
US5830993A (en) * 1995-04-10 1998-11-03 Kansas State University Research Foundation Synthetic antimicrobial peptide

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Huttner K. M. et al. (1998) Gene 206: 85-91 *
Niidome T. et al. (1998) J. Peptide Res. 51: 337-345 *
Niidome T. et al. (2000) Bull. Chem. Soc. Jpn. 73: 1397-1402 *
Shamova O. et al. (1999) Infection and Immunity 67 (8): 4106-4111 *
Tokunaga Y. et al. Journal of Peptide Science 7 (6): 294-304 *

Also Published As

Publication number Publication date
ZA200601999B (en) 2007-02-28
IL174092A (en) 2010-11-30
CA2538085A1 (en) 2005-03-24
CN101113173A (zh) 2008-01-30
CN1878791A (zh) 2006-12-13
WO2005026204A3 (en) 2005-04-28
WO2005026204A2 (en) 2005-03-24
AU2004272170A1 (en) 2005-03-24
BRPI0414253A (pt) 2006-11-21
IL174092A0 (en) 2006-08-01
CA2538085C (en) 2011-03-15
JP2007527228A (ja) 2007-09-27
NZ545815A (en) 2009-11-27
EP1664107A2 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
US7250398B2 (en) Synthetic antimicrobial polypeptides
AU2005238127B2 (en) Antimicrobial polypeptides
ZA200509928B (en) Antimicrobial polypeptides
EP1664095B1 (en) Antimicrobial polypeptides
AU2004272170B2 (en) Synthetic antimicrobial polypeptides

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: NOVOZYMES ADENIUM BIOTECH A/S

Free format text: FORMER APPLICANT(S): NOVOZYMES A/S

MK25 Application lapsed reg. 22.2i(2) - failure to pay acceptance fee